OCP Pretreatment in PCOS Patients Undergoing ICSI Using Antagonist Protocol
Status:
Unknown status
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
373 women with PCOS undergoing a trial of IVF/ICSI will receive OCP from day 2 of the
preceding cycle for 21 days followed by GnRH antagonist COH.
Another 373 women with PCOS undergoing a trial of IVF/ICSI will start GnRH antagonist COH
directly without OCP pretreatment.
Both groups will be followed up for effect on ongoing pregnancy rate.